shares of salarius pharmaceuticals inc slid to an alltime low friday after the clinicalstage biopharmaceutical company said it would raise about 23 million in a dilutive stock sale the houston company said it agreed to sell roughly 93 million shares to a group of institutional investors at 25 cents apiece 36 below thursdays closing price of 34 cents salarius which had about 467 million shares outstanding before the registered direct offering said it plans to use the proceeds to fund clinical and preclinical development of its product candidates salarius said it also agreed to issue unregistered warrants to the investors for the purchase of up to 7 million shares at 34 cents each salarius shares were recently down 23 to an alltime low of 26 cents